News
For years, researchers and patients have hoped that embryonic stem cells (ESCs)—capable of forming nearly any cell type in the body—could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are “primed” and slightly less plastic than the mouse cells.
Air pollution modeling reveals broad-scale impacts of pollution removal by trees.
A new ultra-sensitive, low-cost and portable system for detecting mercury in environmental water has been developed by University of Adelaide researchers.
Human cells make new copies of their DNA billions of times each day, a crucial process upon which life itself depends. However, scientists do not fully understand how cells unzip the double-stranded DNA molecule before replicating both halves of it. New work at Rockefeller may help change that.
A novel combination of microscopy and data processing has given researchers at the Department of Energy’s Oak Ridge National Laboratory an unprecedented look at the surface of a material known for its unusual physical and electrochemical properties.
Companies combine expertise to produce cytomegalovirus vaccine candidates.
Antibacterial clays could be the answer to superbugs.
The size and age of plants has more of an impact on their productivity than temperature and precipitation, University of Arizona researchers have discovered.
A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time could lead to better diagnosis and treatment of gut diseases.
Malvern Instruments Ltd (Malvern, UK) has today (July 25) announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry.
